Ugir Hossain Sk

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Circulating Tumor

Endoplasmic Reticulum Stress

Top Venues

Molecular pharmaceutics

This page only lists publications with an associated author ORCID identifier.

Publications

Debapriya RoyMahapatra, Ranjeet Singh, Ugir Hossain Sk, Partha Pratim Manna
Engineered Artesunate-Naphthalimide Hybrid Dual Drug for Synergistic Multimodal Therapy against Experimental Murine Lymphoma. Molecular pharmaceutics (2024)
Debapriya RoyMahapatra, Ranjeet Singh, Ugir Hossain Sk, Partha Pratim Manna
Engineered Artesunate-Naphthalimide Hybrid Dual Drug for Synergistic Multimodal Therapy against Experimental Murine Lymphoma. Molecular pharmaceutics 21 (3) (2024)
Debapriya RoyMahapatra, Ranjeet Singh, Ugir Hossain Sk, Partha Pratim Manna
Engineered Artesunate-Naphthalimide Hybrid Dual Drug for Synergistic Multimodal Therapy against Experimental Murine Lymphoma. Molecular pharmaceutics 21 (3) (2024)
Rubi Roy, Tasnim Ria, Debapriya RoyMahaPatra, Ugir Hossain Sk
Single Inhibitors versus Dual Inhibitors: Role of HDAC in Cancer. ACS omega 8 (19) (2023)